EKF Diagnostics: looking good, but what next?
Much like every business touching the Covid-19 testing space, shares in EKF Diagnostic (LON:EKF), the global medical manufacturer of point-of-care and central lab devices and chemistry reagents, have had an excellent run over recent months.
The latest trading update confirmed that that full year performance remains in-line with management expectations, which have already been revised upwards several times this year.
While their PrimeStore MTM COVID-19 sample collection device has been…
Sign up and read the full article
Register to continue reading our content.
Get FREE access now
Already a member? Login
Previous article
Next article
More on Arcontech Group
23/02/2021 · Company Insights
Companies covered here have been testing investors' patience with steady, if unspectacular, progress over recent years. One…
02/10/2020 · Company Insights
A provider of software for financial markets covered in our update here looks compelling value and…
More on EKF Diagnostics Holdings
12/01/2021 · Company Insights
There are a broad range of trading updates covered here, but we can’t understand why one company bothered, when…
09/11/2020 · Company Insights
Two pioneering companies supporting the renewable energy arena announced positive developments for their rapidly developing technologies.
More Company Insights
AIM continues to be in good health but…
Cash collection improves, arrears down and expanded funding
Rapidly growing order book highlights the appeal
More on Arcontech Group
More on EKF Diagnostics Holdings
More Company Insights